StockSelector.com
  Research, Select, & Monitor Friday, December 06, 2019 2:05:25 PM ET  
Trade Ideas The Market Industries Stocks Portfolio

 
Ticker Lookup
Amedisys, Inc.$166.22$.85.51%

  Quote | Chart | Valuations | Sentiment | Industry | News | Earnings | Analysts | More...

Your Target?

Amedisys, Inc. has an overall rank of 815 out of 7260 stocks based on 15 positive rankings and 8 negative rankings.

Positive Rankings
Historic EPS Growth
Amedisys rank is 39
Beat Whisper
According to EarningsWhispers.com, Amedisys beat the Earnings Whisper number when it last reported earnings. Statistics show that companies that have beat the Earnings Whisper number outperform the market in the short-term.
Positive Guidance
Within the past 90 days Amedisys has provided guidance above the consensus estimates. Statistics show companies that provide positive guidance outperform the market in the short-term.
Highest ROA
Amedisys rank is 256
Up Estimate Revision
During the past month, the consensus earnings estimate for the current year and next year have increased by a combined 1.09%. Among companies that have had their estimates raised within the past month, Amedisys is ranked 337.
Estimated EPS Growth
Amedisys rank is 438
90 Day Gain
Amedisys rank is 534
Highest ROE
Amedisys rank is 541
Estimated Revenue Growth
Amedisys rank is 649
Up EPS Surprise
Amedisys beat the consensus earnings estimate when it last reported quarterly earnings.
10 Day Gain
Amedisys rank is 668
Debt-to-Equity
Amedisys rank is 1131
Highest Cash Growth
Amedisys rank is 1524
Historic Revenue Growth
Amedisys rank is 1998
Highest Net Margin
Amedisys rank is 2219
Negative Rankings
High/Dropping MACD
The MACD remains positive, but is dropping... suggesting a possible near-term correction. Of companies with a positive, but declining MACD, Amedisys is ranked 37.
Overbought RSI
The 14 Day Relative-Strength Index for Amedisys is 73.0. An RSI above 70 indicates the stock is overbought. Among companies with a high RSI, Amedisys is ranked 226.
Down Ratings Revision
During the past month, the average analyst's rating or recommendation has decreased. Among companies that have been downgraded within the past month, Amedisys is ranked 265.
High vPut/Call
Amedisys has a high Put/Call ratio of 3.07 on active options expiring within the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Amedisys is ranked 369.
Price-to-Book
Amedisys rank is 391
High Put/Call
Amedisys has a high Put/Call ratio of 1.65 on all open interest of options expiring in the next 90 days. A high put-to-call ratio indicates there are more bearish investors than bullish investors for the stock. Among companies with a high Put/Call Ratio, Amedisys is ranked 410.
Overbought Stochastics
Amedisys rank is 501
Price-to-Sales
Amedisys rank is 1848







Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results

StockSelector.com, the StockSelector.com logo, and News Selects are trademarks of StockSelector.com.
Copyright © 1998 - 2019 StockSelector.com. All rights reserved.